A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...
Lung cancer remains a leading cause of cancer-related mortality worldwide, with immune checkpoint inhibitors (ICIs) offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results